Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MDAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -12.05M
March 31, 2026 -8.81M
December 31, 2025 -5.727M
September 30, 2025 -8.203M
June 30, 2025 -9.151M
March 31, 2025 -1.626M
December 31, 2024 -7.251M
September 30, 2024 -4.336M
June 30, 2024 -4.265M
March 31, 2024 -2.028M
December 31, 2023 -1.709M
September 30, 2023 1.456M
Date Value
June 30, 2023 -9.624M
March 31, 2023 -8.590M
December 31, 2022 12.00M
September 30, 2022 241.87M
June 30, 2022
March 31, 2022
December 31, 2021 232.18M
September 30, 2021
June 30, 2021 234.64M
March 31, 2021 237.55M
December 31, 2020 0.0243M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Co-Diagnostics, Inc. 12.71M
Fractyl Health, Inc. -1.665M
NovelStem International Corp. -2.032M
IGC Pharma, Inc. 6.132M
Omnicell, Inc. 1.292B

Shareholders Equity (Quarterly) Related Metrics